Molecular models of NS3 protease variants of the Hepatitis C virus

BACKGROUND: Hepatitis C virus (HCV) currently infects approximately three percent of the world population. In view of the lack of vaccines against HCV, there is an urgent need for an efficient treatment of the disease by an effective antiviral drug. Rational drug design has not been the primary way...

Descripción completa

Detalles Bibliográficos
Autores principales: da Silveira, Nelson JF, Arcuri, Helen A, Bonalumi, Carlos E, de Souza, Fátima P, Mello, Isabel MVGC, Rahal, Paula, Pinho, João RR, de Azevedo, Walter F
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC547903/
https://www.ncbi.nlm.nih.gov/pubmed/15663787
http://dx.doi.org/10.1186/1472-6807-5-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC547903/
https://www.ncbi.nlm.nih.gov/pubmed/15663787
http://dx.doi.org/10.1186/1472-6807-5-1

Ejemplares similares